Sarepta Therapeutics's market cap is currently ―. The company's EPS TTM is CHF1.5053859449999998; its P/E ratio is ―; Sarepta Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is CHF-0.56. See an overview of income statement, balance sheet, and cash flow financials.
